EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye

Ecem Buyukyanbolu, Leyla Genc, Elizabeth A Cyr, Mehmet Karakus, Fusun Comert, Baris Otlu, Elif Aktas, David P Nicolau

European Journal of Clinical Microbiology & Infectious Diseases · 2024-09 · 43 (9) · 1787-1794

DOI: 10.1007/s10096-024-04896-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 12.07.2024. Verfasst von Ecem Buyukyanbolu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. nallarecem@gmail.com. Hauptthemen laut MEDLINE: Drug Combinations, Cephalosporins, Ceftazidime, Azabicyclo Compounds. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CombinationsCephalosporinsCeftazidimeAzabicyclo CompoundsMicrobial Sensitivity TestsPseudomonas aeruginosaPseudomonas InfectionsTazobactamAnti-Bacterial AgentsCefiderocolHumansMiddle AgedFemaleMaleAdultbeta-LactamasesAgedCarbapenemsBacterial ProteinsYoung AdultAdolescentbeta-Lactamase InhibitorsChild

Stichwörter der Autor:innen

Antimicrobial susceptibilityCarbapenem resistanceCefiderocol

Substanzen

Drug CombinationsCephalosporinsCeftazidimeavibactam, ceftazidime drug combinationAzabicyclo Compoundsceftolozane, tazobactam drug combinationTazobactamAnti-Bacterial AgentsCefiderocolcarbapenemase

Autor:innen und Institutionen

  • Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. nallarecem@gmail.com.
  • Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA. nallarecem@gmail.com.
  • Department of Medical Microbiology, Health Sciences University Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
  • Center for Anti-Infective Research & Development, Hartford Hospital, 80 Seymour Street, Hartford, 06102, CT, USA.
  • Department of Medical Microbiology, Health Sciences University, Istanbul, Turkey.
  • Department of Medical Microbiology, Faculty of Medicine, Bulent Ecevit University, Zonguldak, Turkey.

Zitieren

APA

Buyukyanbolu, E., Genc, L., Cyr, E. A., Karakus, M., Comert, F., Otlu, B., Aktas, E., & Nicolau, D. P. (2024). Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye. European Journal of Clinical Microbiology & Infectious Diseases, 43(9), 1787-1794. https://doi.org/10.1007/s10096-024-04896-7

Vancouver

Buyukyanbolu E, Genc L, Cyr EA, Karakus M, Comert F, Otlu B, et al. Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(9):1787-1794. doi:10.1007/s10096-024-04896-7

BibTeX
@article{Buyukyanbolu2024,
  author = {Buyukyanbolu, Ecem and Genc, Leyla and Cyr, Elizabeth A and Karakus, Mehmet and Comert, Fusun and Otlu, Baris and Aktas, Elif and Nicolau, David P},
  title = {Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  volume = {43},
  number = {9},
  pages = {1787--1794},
  doi = {10.1007/s10096-024-04896-7}
}
Kostenlos starten →